French take firmer stance on spending:
This article was originally published in Clinica
The French government aims to overhaul the way it regulates medical expenditure later this year. New bills on modernising healthcare and on financing the social security both contain proposed changes which are designed to place further controls on healthcare expenditure. The ministry responsible for health will hold discussions through the summer months with the medical insurance organisations and medical professionals aimed at establishing new reimbursement rules. Until these have been agreed, professionals who set their own charges (as opposed to using those agreed by the state) will be penalised if they exceed limits for reclaiming fees.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.